HMGB1 and prostate carcinoma: However, a study conducted by Mengus et al. [31] to determine the circulating levels of cytokines in early stage prostate cancer (1 to 2c) showed that HMGB1 levels were not found to be significant when compared to control benign hyperplastic prostate (BPH) samples.